首页> 美国卫生研究院文献>ACS Omega >Ligand-Promoted Iridium-Catalyzed Transfer Hydrogenationof Terminal Alkynes with Ethanol and Its Application
【2h】

Ligand-Promoted Iridium-Catalyzed Transfer Hydrogenationof Terminal Alkynes with Ethanol and Its Application

机译:配体促进的铱催化转移加氢末端炔烃与乙醇的合成及其应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A ligand-promoted iridium-catalyzed transfer hydrogenation of terminal alkynes with ethanol and its application has been developed. Highly chemical selectivity control is achieved based on ligand regulation. 1,2-Bis(diphenylphosphino)ethane was found to be critical for the transfer hydrogenation of alkynes. The general applicability of this procedure is highlighted by the synthesis of 30 terminal alkenes with a good yield. In addition, we conducted drug effect studies of phenelzine using zebrafish as the vertebrate model. Phenelzine shows a significant effect on promoting vascular proliferation and inhibiting nerve growth. The results of these studies have an important reference value for promoting drug research in cerebrovascular diseases, epilepsy, mania, and psychosis.
机译:配体促进的铱催化的末端炔烃与乙醇的转移加氢反应及其应用已得到发展。基于配体调节,可实现高度化学选择性的控制。发现1,2-双(二苯基膦基)乙烷对于炔烃的转移氢化至关重要。该方法的普遍适用性以高收率合成30个末端烯烃而突出。此外,我们使用斑马鱼作为脊椎动物模型进行了苯乙肼的药物作用研究。苯乙嗪对促进血管增殖和抑制神经生长具有显著作用。这些研究结果对促进脑血管疾病,癫痫,躁狂症和精神病方面的药物研究具有重要的参考价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号